From: ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable
ATTR | COVID-19 | References | |
---|---|---|---|
Cardiovascular | HF, rhythm disturbances, conduction block, dyspnea, syncope, palpitations, elevated biomarkers, thromboembolism | HF, myocardial injury, myocarditis, acute coronary syndromes, palpitations, dyspnea, elevated biomarkers, thromboembolism | |
Gastrointestinal | Diarrhea, constipation, loss of appetite, nausea | Diarrhea, loss of appetite, nausea/vomiting, gastroenteritis | |
Hematologic and Immunologic | Increased pro-inflammatory cytokines, increased propensity to left atrial thrombosis | Cytokine storm, venous thrombosis, lymphopenia, venous/arterial thromboembolism, coagulopathy, microangiopathy | |
Musculoskeletal | CTS, spinal stenosis, trigger finger, shoulder, knee and hip surgery | Arthralgia, myalgias | |
Renal | Proteinuria, renal failure | AKI, ATN | |
Neurologic | CNS: headache, ataxia, seizures, stroke-like episodes | Headache, dizziness, seizures, mental status changes, muscle pain, stroke, neuropathy (eg, AIDP), myopathy, myelitis, anosmia, hypogeusia, dysgeusia | |
Peripheral neuropathy: numbness/tingling in hands and feet, neuropathic pain, walking disability, loss of balance | |||
Autonomic neuropathy: urinary retention and incontinence; erectile dysfunction; orthostatic hypotension; gastrointestinal manifestations | |||
Pulmonary | Impairment from alveolar-septal amyloidosis | Cough, shortness of breath, pneumonia, ARDS | |
Pulmonary hypertension due to left-sided heart disease | |||
Other/Constitutional | Unintentional weight loss | Fever, fatigue |